MEDICINOVA, INC. Accumulated Other Comprehensive Income
MEDICINOVA, INC. (MNOV) had Accumulated Other Comprehensive Income of -$127.39 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$127.39K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$128.13K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$127.18K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$126.80K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$127.39K 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$128.13K 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$127.18K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$126.80K 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$127.37K 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$130.05K 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$135.15K 10-K · filed 2026-03-10 |
| 2024-09-30 | -$123.80K 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$131.53K 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$126.98K 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$118.09K 10-K · filed 2025-02-19 |
| 2023-09-30 | -$123.75K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$121.04K 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$116.83K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$115.28K 10-K · filed 2024-02-15 |
| 2022-09-30 | -$124.26K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$118.29K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$106.31K 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$98.88K 10-K/A · filed 2023-03-28 |
| 2021-09-30 | -$95.04K 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$93.68K 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$95.04K 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$88.22K 10-K · filed 2022-02-16 |
| 2020-09-30 | -$90.03K 10-Q · filed 2020-10-26 |
| 2020-06-30 | -$92.80K 10-Q · filed 2020-07-28 |
| 2020-03-31 | -$92.80K 10-Q · filed 2020-04-23 |
| 2019-12-31 | -$92.68K 10-K · filed 2021-02-19 |
| 2019-09-30 | -$92.36K 10-Q · filed 2019-10-24 |
| 2019-06-30 | -$91.58K 10-Q · filed 2019-07-25 |
| 2019-03-31 | -$94.93K 10-Q · filed 2019-04-25 |
| 2018-12-31 | -$93.15K 10-K · filed 2020-02-13 |
| 2018-09-30 | -$93.42K 10-Q · filed 2018-10-25 |
| 2018-06-30 | -$92.81K 10-Q · filed 2018-07-23 |
| 2018-03-31 | -$88.79K 10-Q · filed 2018-04-25 |
| 2017-12-31 | -$94.62K 10-K · filed 2019-02-13 |
| 2017-09-30 | -$94.27K 10-Q · filed 2017-10-23 |
| 2017-06-30 | -$94.78K 10-Q · filed 2017-07-26 |
| 2017-03-31 | -$94.28K 10-Q · filed 2017-04-26 |
| 2016-12-31 | -$96.00K 10-K · filed 2018-02-13 |
| 2016-09-30 | -$84.96K 10-Q · filed 2016-10-25 |
| 2016-06-30 | -$87.56K 10-Q · filed 2016-07-26 |
| 2016-03-31 | -$93.06K 10-Q · filed 2016-04-27 |
| 2015-12-31 | -$102.77K 10-K · filed 2017-02-14 |
| 2015-09-30 | -$101.47K 10-Q · filed 2015-10-29 |
| 2015-06-30 | -$103.30K 10-Q · filed 2015-07-30 |
| 2015-03-31 | -$101.62K 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$100.98K 10-K · filed 2016-02-25 |
| 2014-09-30 | -$84.31K 10-Q · filed 2014-11-13 |
| 2014-06-30 | -$77.34K 10-Q · filed 2014-08-13 |
| 2014-03-31 | -$78.13K 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$80.80K 10-K · filed 2015-03-12 |
| 2013-09-30 | -$77.84K 10-Q · filed 2013-11-07 |
| 2013-06-30 | -$78.59K 10-Q · filed 2013-08-08 |
| 2013-03-31 | -$74.87K 10-Q · filed 2013-05-08 |
| 2012-12-31 | -$67.96K 10-K · filed 2014-03-27 |
| 2012-09-30 | -$58.86K 10-Q · filed 2012-11-08 |
| 2012-06-30 | -$61.73K 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$63.63K 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$56.84K 10-K · filed 2013-03-28 |
| 2011-09-30 | -$55.70K 10-Q · filed 2012-11-08 |
| 2011-06-30 | -$61.05K 10-Q · filed 2012-08-09 |
| 2010-12-31 | -$55.70K 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |